Katherine A. Eade is Director at HARVARD BIOSCIENCE INC (HBIO). They have made 1 open-market trade across 1 company since 2019, most recently 2026-06-09.
CIK 0001721318
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $198K since 2019, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| HBIO | 58,669 | $478K |
Shares reported on the most recent Form 4, priced at the 2026-06-12 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| HBIO | BUY | 2019-08-09 | 2019-08-12 | $2.48 | $198K | +4.7% | +19.9% | +0.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.